350 related articles for article (PubMed ID: 36471428)
1. A functional loop between YTH domain family protein YTHDF3 mediated m
Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
[TBL] [Abstract][Full Text] [Related]
2. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
[TBL] [Abstract][Full Text] [Related]
3.
Zheng J; Luo J; Zeng H; Guo L; Shao G
Biomed Pharmacother; 2019 Nov; 119():109402. PubMed ID: 31514072
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
5. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J
Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090
[TBL] [Abstract][Full Text] [Related]
6. m
Hu B; Gao J; Shi J; Wen P; Guo W; Zhang S
Mol Carcinog; 2023 Oct; 62(10):1599-1614. PubMed ID: 37449789
[TBL] [Abstract][Full Text] [Related]
7. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
[TBL] [Abstract][Full Text] [Related]
8. N
Liu D; Li Z; Zhang K; Lu D; Zhou D; Meng Y
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4601-4610. PubMed ID: 36171455
[TBL] [Abstract][Full Text] [Related]
9. EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL.
Pan M; Luo M; Liu L; Chen Y; Cheng Z; Wang K; Huang L; Tang N; Qiu J; Huang A; Xia J
J Exp Clin Cancer Res; 2024 Jan; 43(1):35. PubMed ID: 38287371
[TBL] [Abstract][Full Text] [Related]
10. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
[TBL] [Abstract][Full Text] [Related]
11. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
Zhang H; Su X; Burley SK; Zheng XFS
Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
[No Abstract] [Full Text] [Related]
12. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
13. Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma.
Lv C; Li XJ; Hao LX; Zhang S; Song Z; Ji XD; Gong B
Clin Transl Oncol; 2022 Jan; 24(1):93-103. PubMed ID: 34282556
[TBL] [Abstract][Full Text] [Related]
14. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m
Wang M; Yang Y; Yang J; Yang J; Han S
Life Sci; 2020 Sep; 257():118082. PubMed ID: 32653519
[TBL] [Abstract][Full Text] [Related]
15. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
[TBL] [Abstract][Full Text] [Related]
17. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
[TBL] [Abstract][Full Text] [Related]
18. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
19. DNAAF5 promotes hepatocellular carcinoma malignant progression by recruiting USP39 to improve PFKL protein stability.
Liu Y; Wu Q; Sun T; Huang J; Han G; Han H
Front Oncol; 2022; 12():1032579. PubMed ID: 36276075
[TBL] [Abstract][Full Text] [Related]
20. LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation.
Chen B; Xu X; Wu W; Zheng K; Yu Y
Anal Cell Pathol (Amst); 2023; 2023():5852963. PubMed ID: 37234237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]